Exact Sciences Investor Relations Material
Latest events
AGM 2025
Exact Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Exact Sciences Corporation
Access all reports
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States. The company operates through its three business segments: Colorectal Cancer Screening, Breast Cancer Detection, and ColoPath Products. It offers Cologuard, a diagnostic colon test for preventing colorectal cancer;Virtual Colonoscopy, a colorectal cancer screening test that uses 5-10 minutes of transmission of images of the digestive tract to provide virtual visualization of intestines; Cologuard GI, which offers Cologuard to patients at a subsidized price; and Fecal DNA Test that is designed to screen patients at high risk for hereditary nonpolyposis colorectal cancers (Lynch syndrome) or people who are not candidates for Virtual Colonoscopy. Exact Sciences Corporation is based in Madison, Wisconsin.
Key slides for Exact Sciences Corporation
Corporate Presentation
Exact Sciences Corporation
Corporate Presentation
Exact Sciences Corporation
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
EXAS
Country
🇺🇸 United States